financetom
Business
financetom
/
Business
/
LinkedIn disables tool for targeted ads to comply with EU tech rules
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LinkedIn disables tool for targeted ads to comply with EU tech rules
Jun 7, 2024 10:07 AM

BRUSSELS, June 7 (Reuters) - Microsoft's ( MSFT )

LinkedIn has discontinued a tool that allows it to use sensitive

personal data for targeted advertising in order to comply with

EU online content rules, the social media platform said on

Friday.

The move by the company followed a complaint by civil

society organisations to the European Commission, which also

acts as the tech watchdog for the 27-country bloc.

Under the Digital Services Act (DSA), online intermediaries

are required to give users more control on the use of their

data, with an option for them to turn off personalised content.

Companies are not allowed to use sensitive personal data

such as race, sexual orientation or political opinions for their

targeted ads.

The Commission had in March sent a request for information

to LinkedIn after the groups said the tool may allow advertisers

to target LinkedIn users based on racial or ethnic origin,

political opinions and other personal data due to their

membership of LinkedIn groups.

"We've decided to adjust those tools by removing the ability

to create an advertising audience in Europe that uses membership

in LinkedIn Groups as an input," LinkedIn's Vice President

Patrick Corrigan said in a LinkedIn post.

"We made this change to prevent any misconception that ads

to European members could be indirectly targeted based on

special categories of data or related profiling categories," he

said.

EU industry chief Thierry Breton welcomed the move.

"The Commission will monitor the effective implementation of

LinkedIn's public pledge to ensure full compliance with the

DSA," he said in a statement.

Complainants European Digital Rights (EDRi), Gesellschaft

für Freiheitsrechte (GFF), Global Witness and Bits of Freedom

cheered the LinkedIn move.

"Forced by Europe to act, LinkedIn must now widen this

policy to users everywhere and ensure it's not just those in

Europe who are protected from invasive ad targeting," Global

Witness' Nienke Palstra said in a statement.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AI traffic firm Rekor's Q3 revenue jumps, driven by license sales
AI traffic firm Rekor's Q3 revenue jumps, driven by license sales
Nov 13, 2025
Overview * Rekor ( REKR ) Q3 revenue rises 35% yr/yr to $14.2 mln, driven by license sales * Adjusted EBITDA loss narrows to $1.5 mln, best in company history * Rekor ( REKR ) secures $50 mln contract with Georgia DOT, potential to exceed $100 mln Outlook * Company did not provide specific financial guidance for future quarters or...
Sera Prognostics Q3 net loss narrows
Sera Prognostics Q3 net loss narrows
Nov 13, 2025
Overview * Sera Prognostics Q3 2025 revenue was $16,000 * Net loss for Q3 2025 was $7.8 mln, slightly improved from last year * Company progresses on Medicaid pilot in Nevada, engaging with multiple payers Outlook * Company is advancing discussions with Medicaid plans covering 33% of U.S. births * Company aims to secure broad coverage at employer, plan, and...
Medical tech firm STRATA's Q3 revenue misses estimates as demand in international markets softens
Medical tech firm STRATA's Q3 revenue misses estimates as demand in international markets softens
Nov 13, 2025
Overview * STRATA Q3 2025 revenue fell 21% yr/yr, missing analyst expectations * Net loss for Q3 2025 reduced to $1.6 mln from $2.1 mln yr/yr * Company's recurring revenue increased 3% yr/yr, equipment revenue fell 60% Outlook * STRATA anticipates revenue growth from expanded CPT codes for reimbursement * STRATA plans to manage costs and expand patient pool through...
Genome mapping firm Bionano Q3 rev beats estimates on higher utilization by routine users
Genome mapping firm Bionano Q3 rev beats estimates on higher utilization by routine users
Nov 13, 2025
Overview * Bionano Q3 2025 revenue grows 21% yr/yr, beating analyst expectations * Company's gross margin improves to 46% from (139)% in Q3 2024 * Operating expenses reduced by 66% to $11.9 mln Outlook * Bionano expects Q4 2025 revenue between $7.5 mln and $7.9 mln * Company maintains full-year 2025 revenue guidance of $26 mln to $30 mln *...
Copyright 2023-2026 - www.financetom.com All Rights Reserved